Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, indicating a site software/content management update rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T22:41:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:18:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:59.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:23.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior funding-status notice as well as Revision: v3.4.1. These changes appear to be maintenance updates and do not alter the trial details or patient-facing information on the page.
    Difference
    0.4%
    Check dated 2026-02-11T21:37:48.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's current status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T11:23:15.000Z thumbnail image

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.